About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time, this means that 70 per cent of all melanoma patients still have no effective treatment option. Göran Jönsson and his colleagues want to identify new drugs for this patient group.
“It is a remarkably prestigious grant and we are very pleased. It means that together with my co-applicant, I now have the time and resources to pose the important questions concerning immunotherapy, tertiary lymphoid structures and melanoma cancer. We have many ideas and thoughts that we can now work on and develop in order to understand the fundamental mechanisms that explain why not all melanoma patients benefit from immunotherapy,” says Göran Jönsson.
Three more researchers at Lund University received project grants from the Knut and Alice Wallenberg Foundation Mikael Akke, Sara Linse and Michel Gisselbrecht at the Faculty of Science and Engineering. Read more here: Four Lund researchers receive SEK 120 million from the Knut and Alice Wallenberg Foundation
This year, the Knut and Alice Wallenberg Foundation is granting a total of SEK 700 million to 23 innovative basic research projects at Swedish higher education institutions.
Link to original article in Swedish published 14 October 2022